Kelyniam Global IncOTC Pink - Current Information:KLYG
- LAST PRICE0.1750
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1700/ 60
- Ask / Lots0.1900/ 310
- Open / Previous Close--- / 0.1750
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kelyniam Global Inc | 5.4M | -6.9x | --- |
Aethlon Medical Inc | 5.2M | -0.1x | --- |
Autonomix Medical Inc | 5.9M | -0.2x | --- |
ALR Technologies Inc | 6.4M | -0.7x | --- |
HeartSciences Inc | 3.6M | -0.7x | --- |
Catheter Precision Inc | 3.0M | 0.0x | --- |
Company Information
Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company specializing in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, its 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours. It distributes its products throughout the United States via independent distributors and sales representatives.
Contact Information
- Headquarters
- 97 River RdCOLLINSVILLE, CT, United States 06019-3246
- Phone
- 800-280-8192
- Fax
- 501-641-2000
Executives
- Chairman of the Board, Chief Executive Officer
- Ross Bjella
- Chief Financial Officer
- Terrance Kurtenbach
- Chief Operating Officer
- Christopher Breault
- Vice President - Sales and Marketing
- Mark Chenoweth
- Vice President - Sales and Business Development
- Mark Smith
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.4M |
|---|---|
Revenue (TTM) | $517.7K |
Shares Outstanding | 30.7M |
Kelyniam Global Inc does not pay a dividend. | |
Beta | -1.27 |
EPS | $-0.03 |
Book Value | $0.00 |
P/E Ratio | -6.9x |
Price/Sales (TTM) | 10.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -93.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
